MiR-141 dramatically boosted the level of phosphorylated AKT in NSCLC cells while deregulating the inhibitory effects of PHLPP1 and PHLPP2, which block the PI3K/AKT signaling pathway and slow NSCLC cell proliferation (23). The gene discussed is PIK3CD; the disease is non-small cell lung carcinoma.